| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. BRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 187.5K | $34.9K | - | |
| VP | 171.4K | $31.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 500 | $3.91 | $1,955.95 | +0.3% | -12.3% | +45.7% | |
| Jun 13, 2022 | Broadrick Dale60 | - | Buy | 1,300 | $3.92 | $5,096.52 | +0.4% | -16.1% | +36.1% | |
| Jun 13, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 200 | $3.95 | $790.00 | - | -16.1% | +36.1% | |
| Jun 10, 2022 | Broadrick Dale60 | - | Buy | 1,600 | $4.25 | $6,805.68 | +0.3% | -20.2% | +25.3% | |
| Jun 8, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 100 | $4.28 | $428.00 | - | -25.1% | +23.5% | |
| Jun 8, 2022 | Broadrick Dale60 | - | Buy | 6,000 | $4.57 | $27,398.28 | +1.1% | -25.1% | +23.5% | |
| Jun 7, 2022 | Kristal Robert Eugene | Chief Financial Officer | Buy | 200 | $4.56 | $912.00 | +2.6% | -31.1% | +15.2% | |
| Jun 6, 2022 | Broadrick Dale60 | - | Buy | 4,200 | $4.92 | $20,676.78 | +0.8% | -33.2% | +9.2% | |
| Jun 2, 2022 | Broadrick Dale60 | - | Buy | 1,000 | $4.69 | $4,687.80 | +0.4% | -32.7% | +9.9% | |
| Jun 1, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 200 | $4.60 | $920.00 | +0.1% | -29.1% | +19.3% |